Old drug may have new tricks for fighting cancer

(Arizona State University) Results show that the drug ibrutinib acts as a potent kinase inhibitor for ERBB4, limits growth in human cancer cells in the laboratory, and reduces tumor size in mice. The sensitivity of ERBB4 to ibrutinib is similar to that of BTK, the original target of the drug.
Source: EurekAlert! - Biology - Category: Biology Source Type: news